Theranostic Nanoseeds for Efficacious Internal Radiation Therapy of Unresectable Solid Tumors

Sina Moeendarbari, Rakesh Tekade, Aditi Mulgaonkar, Preston Christensen, Saleh Ramezani, Gedaa Hassan, Ruiqian Jiang, Orhan K. Öz, Yaowu Hao, Xiankai Sun

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Malignant tumors are considered â œ unresectableâ if they are adhere to vital structures or the surgery would cause irreversible damages to the patients. Though a variety of cytotoxic drugs and radiation therapies are currently available in clinical practice to treat such tumor masses, these therapeutic modalities are always associated with substantial side effects. Here, we report an injectable nanoparticle-based internal radiation source that potentially offers more efficacious treatment of unresectable solid tumors without significant adverse side effects. Using a highly efficient incorporation procedure, palladium-103, a brachytherapy radioisotope in clinical practice, was coated to monodispersed hollow gold nanoparticles with a diameter about 120 nm, to form 103 Pd@Au nanoseeds. The therapeutic efficacy of 103 Pd@Au nanoseeds were assessed when intratumorally injected into a prostate cancer xenograft model. Five weeks after a single-dose treatment, a significant tumor burden reduction (>80%) was observed without noticeable side effects on the liver, spleen and other organs. Impressively, >95% nanoseeds were retained inside the tumors as monitored by Single Photon Emission Computed Tomography (SPECT) with the gamma emissions of 103 Pd. These findings show that this nanoseed-based brachytherapy has the potential to provide a theranostic solution to unresectable solid tumors.

Original languageEnglish (US)
Article number20614
JournalScientific Reports
Volume6
DOIs
StatePublished - Feb 8 2016

Fingerprint

Radiotherapy
Brachytherapy
Neoplasms
Nanoparticles
Palladium
Therapeutics
Single-Photon Emission-Computed Tomography
Tumor Burden
Heterografts
Gold
Prostatic Neoplasms
Spleen
Theranostic Nanomedicine
Radiation
Drug Therapy
Injections
Liver

ASJC Scopus subject areas

  • General

Cite this

Moeendarbari, S., Tekade, R., Mulgaonkar, A., Christensen, P., Ramezani, S., Hassan, G., ... Sun, X. (2016). Theranostic Nanoseeds for Efficacious Internal Radiation Therapy of Unresectable Solid Tumors. Scientific Reports, 6, [20614]. https://doi.org/10.1038/srep20614

Theranostic Nanoseeds for Efficacious Internal Radiation Therapy of Unresectable Solid Tumors. / Moeendarbari, Sina; Tekade, Rakesh; Mulgaonkar, Aditi; Christensen, Preston; Ramezani, Saleh; Hassan, Gedaa; Jiang, Ruiqian; Öz, Orhan K.; Hao, Yaowu; Sun, Xiankai.

In: Scientific Reports, Vol. 6, 20614, 08.02.2016.

Research output: Contribution to journalArticle

Moeendarbari, S, Tekade, R, Mulgaonkar, A, Christensen, P, Ramezani, S, Hassan, G, Jiang, R, Öz, OK, Hao, Y & Sun, X 2016, 'Theranostic Nanoseeds for Efficacious Internal Radiation Therapy of Unresectable Solid Tumors', Scientific Reports, vol. 6, 20614. https://doi.org/10.1038/srep20614
Moeendarbari S, Tekade R, Mulgaonkar A, Christensen P, Ramezani S, Hassan G et al. Theranostic Nanoseeds for Efficacious Internal Radiation Therapy of Unresectable Solid Tumors. Scientific Reports. 2016 Feb 8;6. 20614. https://doi.org/10.1038/srep20614
Moeendarbari, Sina ; Tekade, Rakesh ; Mulgaonkar, Aditi ; Christensen, Preston ; Ramezani, Saleh ; Hassan, Gedaa ; Jiang, Ruiqian ; Öz, Orhan K. ; Hao, Yaowu ; Sun, Xiankai. / Theranostic Nanoseeds for Efficacious Internal Radiation Therapy of Unresectable Solid Tumors. In: Scientific Reports. 2016 ; Vol. 6.
@article{3b82d5c25f6949a4950718cdd268d05b,
title = "Theranostic Nanoseeds for Efficacious Internal Radiation Therapy of Unresectable Solid Tumors",
abstract = "Malignant tumors are considered {\^a} œ unresectable{\^a} if they are adhere to vital structures or the surgery would cause irreversible damages to the patients. Though a variety of cytotoxic drugs and radiation therapies are currently available in clinical practice to treat such tumor masses, these therapeutic modalities are always associated with substantial side effects. Here, we report an injectable nanoparticle-based internal radiation source that potentially offers more efficacious treatment of unresectable solid tumors without significant adverse side effects. Using a highly efficient incorporation procedure, palladium-103, a brachytherapy radioisotope in clinical practice, was coated to monodispersed hollow gold nanoparticles with a diameter about 120 nm, to form 103 Pd@Au nanoseeds. The therapeutic efficacy of 103 Pd@Au nanoseeds were assessed when intratumorally injected into a prostate cancer xenograft model. Five weeks after a single-dose treatment, a significant tumor burden reduction (>80{\%}) was observed without noticeable side effects on the liver, spleen and other organs. Impressively, >95{\%} nanoseeds were retained inside the tumors as monitored by Single Photon Emission Computed Tomography (SPECT) with the gamma emissions of 103 Pd. These findings show that this nanoseed-based brachytherapy has the potential to provide a theranostic solution to unresectable solid tumors.",
author = "Sina Moeendarbari and Rakesh Tekade and Aditi Mulgaonkar and Preston Christensen and Saleh Ramezani and Gedaa Hassan and Ruiqian Jiang and {\"O}z, {Orhan K.} and Yaowu Hao and Xiankai Sun",
year = "2016",
month = "2",
day = "8",
doi = "10.1038/srep20614",
language = "English (US)",
volume = "6",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Theranostic Nanoseeds for Efficacious Internal Radiation Therapy of Unresectable Solid Tumors

AU - Moeendarbari, Sina

AU - Tekade, Rakesh

AU - Mulgaonkar, Aditi

AU - Christensen, Preston

AU - Ramezani, Saleh

AU - Hassan, Gedaa

AU - Jiang, Ruiqian

AU - Öz, Orhan K.

AU - Hao, Yaowu

AU - Sun, Xiankai

PY - 2016/2/8

Y1 - 2016/2/8

N2 - Malignant tumors are considered â œ unresectableâ if they are adhere to vital structures or the surgery would cause irreversible damages to the patients. Though a variety of cytotoxic drugs and radiation therapies are currently available in clinical practice to treat such tumor masses, these therapeutic modalities are always associated with substantial side effects. Here, we report an injectable nanoparticle-based internal radiation source that potentially offers more efficacious treatment of unresectable solid tumors without significant adverse side effects. Using a highly efficient incorporation procedure, palladium-103, a brachytherapy radioisotope in clinical practice, was coated to monodispersed hollow gold nanoparticles with a diameter about 120 nm, to form 103 Pd@Au nanoseeds. The therapeutic efficacy of 103 Pd@Au nanoseeds were assessed when intratumorally injected into a prostate cancer xenograft model. Five weeks after a single-dose treatment, a significant tumor burden reduction (>80%) was observed without noticeable side effects on the liver, spleen and other organs. Impressively, >95% nanoseeds were retained inside the tumors as monitored by Single Photon Emission Computed Tomography (SPECT) with the gamma emissions of 103 Pd. These findings show that this nanoseed-based brachytherapy has the potential to provide a theranostic solution to unresectable solid tumors.

AB - Malignant tumors are considered â œ unresectableâ if they are adhere to vital structures or the surgery would cause irreversible damages to the patients. Though a variety of cytotoxic drugs and radiation therapies are currently available in clinical practice to treat such tumor masses, these therapeutic modalities are always associated with substantial side effects. Here, we report an injectable nanoparticle-based internal radiation source that potentially offers more efficacious treatment of unresectable solid tumors without significant adverse side effects. Using a highly efficient incorporation procedure, palladium-103, a brachytherapy radioisotope in clinical practice, was coated to monodispersed hollow gold nanoparticles with a diameter about 120 nm, to form 103 Pd@Au nanoseeds. The therapeutic efficacy of 103 Pd@Au nanoseeds were assessed when intratumorally injected into a prostate cancer xenograft model. Five weeks after a single-dose treatment, a significant tumor burden reduction (>80%) was observed without noticeable side effects on the liver, spleen and other organs. Impressively, >95% nanoseeds were retained inside the tumors as monitored by Single Photon Emission Computed Tomography (SPECT) with the gamma emissions of 103 Pd. These findings show that this nanoseed-based brachytherapy has the potential to provide a theranostic solution to unresectable solid tumors.

UR - http://www.scopus.com/inward/record.url?scp=84957584263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957584263&partnerID=8YFLogxK

U2 - 10.1038/srep20614

DO - 10.1038/srep20614

M3 - Article

C2 - 26852805

AN - SCOPUS:84957584263

VL - 6

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 20614

ER -